Abstract
Purpose
Patients with chronic obstructive pulmonary disease (COPD), which is predicted to be the third most common cause of death worldwide by 2020, often suffer from depression, one of the most common and modifiable comorbidities of COPD. This study assessed the prevalence of depression in patients with COPD and the association of depression with disease severity.
Methods
This was a multicenter, prospective cross-sectional study of 245 patients with stable COPD. Disease severity was assessed using two scales: the global initiative for chronic obstructive lung disease (GOLD) stage and BODE index. Depression was measured using the Centers for Epidemiologic Studies Depression (CES-D) scales. Data were analyzed using descriptive statistics, Spearman correlation, and multivariate logistic regression.
Results
Depression defined as a CES-D score of 24 and higher was observed in 17.6 % of patients with COPD. The prevalence of depression increased with disease severity based on the BODE quartile (r = 0.16; P = 0.014). By contrast, no difference was observed in the prevalence of depression among the severity groups using the GOLD staging system (r = − 0.01; P = 0.898). Elementary school graduates were more likely to experience depression than graduates of high school and above [odds ratio (OR) = 3.67; 95 % confidence interval (CI) 1.37–9.85] and patients in BODE quartile II were more likely to experience depression than those with BODE quartile I (OR = 2.5; 95 % CI 1.04–6.06).
Conclusions
Depression was associated with disease severity according to the BODE quartile in patients with COPD. BODE quartile II was a significant predictor of depression. Screening patients with a high risk of depression and proactive intervention for those patients are needed.
Similar content being viewed by others
References
Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J, Agusti A, Brightling C, Cambon-Thomsen A, Cesario A et al (2011) Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 3(7):43
Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370(9589):765–773
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB et al (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370(9589):741–750
Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167(1):60–67
van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schadé E (2002) Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 57(5):412–416
Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P (2005) Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 26(3):414–419
Ries AL (2006) Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med 119(10 Suppl 1):12–20
Kawamura T, Shioiri T, Takahashi K, Ozdemir V, Someya T (2007) Survival rate and causes of mortality in the elderly with depression: a 15-year prospective study of a Japanese community sample, the Matsunoyama-Niigata suicide prevention project. J Investig Med 55(3):106–114
Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R (2007) Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med 69(4):323–331
Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, Wang C, Bourbeau J (2008) Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 178(9):913–920
Wagena EJ, Kant I, van Amelsvoort LG, Wouters EF, van Schayck CP, Swaen GM (2004) Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking. Psychosom Med 66(5):729–734
Yohannes AM, Baldwin RC, Connolly MJ (2000) Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 15(12):1090–1096
Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag 31(1):58–69
Gallo JJ, Bogner HR, Morales KH, Post EP, Lin JY, Bruce ML (2007) The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial. Ann Intern Med 146(10):689–698
Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME (2006) Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 47(4):312–319
Jordan N, Lee TA, Valenstein M, Weiss KB (2007) Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med 22(10):1447–1452
Mahler DA, Weinberg DH, Wells CK, Feinstein AR (1984) The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 85(6):751–758
Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320(7245):1297–1303
Alsaeedi A, Sin DD, McAlister FA (2002) The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 113(1):59–65
Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR (2004) The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23(1):28–33
Agusti A, Thomas A. Neff Lecture (2006) Chronic obstructive pulmonary disease: a systemic disease. Proc Am Thorac Soc 3(6):478–481
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012
Ong KC, Earnest A, Lu SJ (2005) A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 128(6):3810–3816
Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT (2000) Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis 6(2):75–80
The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2008. http://www.goldcopd.org
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54(7):581–586
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338
Haringsma R, Engels GI, Beekman AT, Spinhoven P (2004) The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry 19(6):558–563
Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183(5):604–611
Shafer AB (2006) Meta-analysis of the factor structures of four depression questionnaires Beck, CES-D, Hamilton, and Zung. J Clin Psychol 62(1):123–146
Chiu S, Webber MP, Zeig-Owens R, Gustave J, Lee R, Kelly KJ, Rizzotto L, Prezant DJ (2010) Validation of the Center for Epidemiologic Studies Depression Scale in screening for major depressive disorder among retired firefighters exposed to the World Trade Center disaster. J Affect Disord 121(3):212–219
Shin S, Kim M, Yun K, Kim J, Lee M, Moon S, Lee M, Lee H, Yoo K (1991) The Center for Epidemiologic Studies-Depression Scale: its use in Korea. J Korean Neuropsychiatr Assoc 30(4):752–767
Funk GC, Kirchheiner K, Burghuber OC, Hartl S (2009) BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD: a cross-sectional study. Respir Res 10:1
An L, Lin YX, Yang T, Zhang H, Jiao X, Zhang S, Chang XH, Wang ZM, Wang C (2010) Predictive validity of BODE index for anxious and depressive symptoms in patients with chronic obstructive pulmonary disease. Chin Med J (Engl) 123(14):1845–1851
Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J (2009) Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 103(10):1572–1579
Lamers F, Jonkers CC, Bosma H, Penninx BW, Knottnerus JA, van Eijk JT (2008) Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol 61(7):679–687
Julian LJ, Gregorich SE, Earnest G, Eisner MD, Chen H, Blanc PD, Yelin EH, Katz PP (2009) Screening for depression in chronic obstructive pulmonary disease. COPD 6(6):452–458
Puhan MA, Frey M, Büchi S, Schünemann HJ (2008) The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 6:46
Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, Dragomirecka E, Kohn R, Keller M, Kessler RC et al (2003) The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 12(1):3–21
Chavannes NH, Huibers MJ, Schermer TR, Hendriks A, van Weel C, Wouters EF, van Schayck CP (2005) Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract 22(6):604–607
von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H (2011) The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 140(3):730–736
Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S (2000) Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 41(6):465–471
Almagro P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, Heredia JL, Garau J (2002) Mortality after hospitalization for COPD. Chest 121(5):1441–1448
Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA et al (2000) Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355(9201):362–368
Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S, Whyte K (2002) Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 20(2):306–312
Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M (2001) Effect of a self-management program on patients with chronic disease. Eff Clin Pract 4(6):256–262
Acknowledgments
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0088833) and Pusan National University Research Grant, 2013.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, K.U., Park, HK., Jung, H.Y. et al. Association of Depression with Disease Severity in Patients with Chronic Obstructive Pulmonary Disease. Lung 192, 243–249 (2014). https://doi.org/10.1007/s00408-013-9547-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-013-9547-4